NSC |
Compound |
Enrichment |
Correlation |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.011265111688021 |
0.045324504 |
NSC 718564 |
Null |
0.011265111688021 |
0.33181061 |
NSC 718781 |
Erlotinib hydrochloride |
0.011265111688021 |
-0.064834875 |
NSC 743433 |
8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one |
0.011265111688021 |
0.3705421 |
NSC 762901 |
trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide |
0.011265111688021 |
0.052637031 |
NSC 90736 |
Null |
0.011265111688021 |
0.28207773 |
NSC 727350 |
benzoanthracenone |
0.011544784012433 |
0.21266724 |
NSC 728856 |
5,6-Dihydro-6-[3-(3-imidazolylpropyl)amino-1-propyl]-5,11-di oxo-11H-indeno[1,2-c]isoquinoline dihdrochloride |
0.011544784012433 |
0.27877943 |
NSC 731589 |
Null |
0.011544784012433 |
0.25045035 |
NSC 734201 |
Null |
0.011544784012433 |
-0.0089302586 |